TD Private Client Wealth’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.5K | Sell |
|
|||||
|
2025
Q1 | $1.28M | Sell |
|
|||||
|
2024
Q4 | $1.67M | Sell |
|
|||||
|
2024
Q3 | $1.84M | Sell |
|
|||||
|
2024
Q2 | $2.53M | Sell |
|
|||||
|
2024
Q1 | $3.32M | Buy |
|
|||||
|
2023
Q4 | $2.28M | Sell |
|
|||||
|
2023
Q3 | $1.94M | Sell |
|
|||||
|
2023
Q2 | $2.24M | Sell |
|
|||||
|
2023
Q1 | $2.16M | Sell |
|
|||||
|
2022
Q4 | $2.41M | Sell |
|
|||||
|
2022
Q3 | $2.48M | Sell |
|
|||||
|
2022
Q2 | $2.76M | Sell |
|
|||||
|
2022
Q1 | $3.87M | Buy |
|
|||||
|
2021
Q4 | $4.61M | Sell |
|
|||||
|
2021
Q3 | $5.31M | Buy |
|
|||||
|
2021
Q2 | $4.75M | Sell |
|
|||||
|
2021
Q1 | $5.71M | Sell |
|
|||||
|
2020
Q4 | $4.95M | Buy |
|
|||||
|
2020
Q3 | $4.35M | Sell |
|
|||||
|
2020
Q2 | $3.4M | Buy |
|
|||||
|
2020
Q1 | $2.24M | Sell |
|
|||||
|
2019
Q4 | $2.86M | Buy |
|